Related references
Note: Only part of the references are listed.Mucosal vaccines - fortifying the frontiers
Ed C. Lavelle et al.
NATURE REVIEWS IMMUNOLOGY (2022)
Modulation of immune responses to vaccination by the microbiota: implications and potential mechanisms
David J. Lynn et al.
NATURE REVIEWS IMMUNOLOGY (2022)
Oral MucoRice-CTB vaccine for safety and microbiota-dependent immunogenicity in humans: a phase 1 randomised trial
Yoshikazu Yuki et al.
LANCET MICROBE (2021)
Mice with diverse microbial exposure histories as a model for preclinical vaccine testing
Jessica K. Fiege et al.
CELL HOST & MICROBE (2021)
A reactive vaccination campaign with single dose oral cholera vaccine (OCV) during a cholera outbreak in Cameroon
Adidja Amani et al.
VACCINE (2021)
Correlates of Protection for Cholera
Anita S. Iyer et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
Effectiveness of a killed whole-cell oral cholera vaccine in Bangladesh: further follow-up of a cluster-randomised trial
Mohammad Ali et al.
LANCET INFECTIOUS DISEASES (2021)
Dissecting serotype-specific contributions to live oral cholera vaccine efficacy
Brandon Sit et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Scalable production and immunogenicity of a cholera conjugate vaccine
Suhi Jeon et al.
VACCINE (2021)
Parenteral Vaccination with a Cholera Conjugate Vaccine Boosts Vibriocidal and Anti-OSP Responses in Mice Previously Immunized with an Oral Cholera Vaccine
Aklima Akter et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2021)
Protection from Lethal Clostridioides difficile Infection via Intraspecies Competition for Cogerminant
Jhansi L. Leslie et al.
MBIO (2021)
Vibrio cholerae Sialidase-Specific Immune Responses Are Associated with Protection against Cholera
M. Hasanul Kaisar et al.
MSPHERE (2021)
Modern History of Cholera Vaccines and the Pivotal Role of icddr,b
Jan Holmgren
JOURNAL OF INFECTIOUS DISEASES (2021)
Protection afforded by previous Vibrio cholerae infection against subsequent disease and infection: A review
Tiffany Leung et al.
PLOS NEGLECTED TROPICAL DISEASES (2021)
Longitudinal analysis of human humoral responses after vaccination with a live attenuated V. cholerae vaccine
Oluwaseyi Adekunle et al.
PLOS NEGLECTED TROPICAL DISEASES (2021)
Vaccination induces rapid protection against bacterial pneumonia via training alveolar macrophage in mice
Hao Gu et al.
ELIFE (2021)
Systemic, Mucosal, and Memory Immune Responses following Cholera
Edward T. Ryan et al.
TROPICAL MEDICINE AND INFECTIOUS DISEASE (2021)
The Interface of Vibrio cholerae and the Gut Microbiome
Jennifer Y. Cho et al.
GUT MICROBES (2021)
A guide to vaccinology: from basic principles to new developments
Andrew J. Pollard et al.
NATURE REVIEWS IMMUNOLOGY (2021)
TheVibrio choleraetype VI secretion system: toxins, regulators and consequences
Cristian Crisan et al.
ENVIRONMENTAL MICROBIOLOGY (2020)
A single dose of a vesicular stomatitis virus-based influenza vaccine confers rapid protection against H5 viruses from different clades
Wakako Furuyama et al.
NPJ VACCINES (2020)
Combined Prebiotic and Microbial Intervention Improves Oral Cholera Vaccination Responses in a Mouse Model of Childhood Undernutrition
Blanda Di Luccia et al.
CELL HOST & MICROBE (2020)
Interpersonal Gut Microbiome Variation Drives Susceptibility and Resistance to Cholera Infection
Salma Alavi et al.
CELL (2020)
Transient Intestinal Colonization by a Live-Attenuated Oral Cholera Vaccine Induces Protective Immune Responses in Streptomycin-Treated Mice
Bolutife Fakoya et al.
JOURNAL OF BACTERIOLOGY (2020)
Humans Surviving Cholera Develop Antibodies against Vibrio cholerae O-Specific Polysaccharide That Inhibit Pathogen Motility
Richelle C. Charles et al.
MBIO (2020)
Development of Hillchol®, a low-cost inactivated single strain Hikojima oral cholera vaccine
Tarun Sharma et al.
VACCINE (2020)
Outer membrane vesicle vaccines
Francesca Micoli et al.
SEMINARS IN IMMUNOLOGY (2020)
Estimating cholera incidence with cross-sectional serology
Andrew S. Azman et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Vibriocidal Titer and Protection From Cholera in Children
Alaina S. Ritter et al.
OPEN FORUM INFECTIOUS DISEASES (2019)
Analysis of lipoprotein transport depletion in Vibrio cholerae using CRISPRi
Florence Caro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Use of controlled human infection models (CHIMs) to support vaccine development: US regulatory considerations
Roshan Ramanathan et al.
VACCINE (2019)
Oral immunization with a probiotic cholera vaccine induces broad protective immunity against Vibrio cholerae colonization and disease in mice
Brandon Sit et al.
PLOS NEGLECTED TROPICAL DISEASES (2019)
Vibrio cholerae at the Intersection of Immunity and the Microbiome
Ana A. Weil et al.
MSPHERE (2019)
Herd protection of unvaccinated adults by oral cholera vaccines in rural Bangladesh
Mohammad Ali et al.
INTERNATIONAL HEALTH (2019)
A Self-Assembling Whole-Cell Vaccine Antigen Presentation Platform
Julie Liao et al.
JOURNAL OF BACTERIOLOGY (2018)
Single-Dose Cholera Vaccine in Response to an Outbreak in Zambia
Eva Ferreras et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Antagonism toward the intestinal microbiota and its effect on Vibrio cholerae virulence
Wenjing Zhao et al.
SCIENCE (2018)
A live vaccine rapidly protects against cholera in an infant rabbit model
Troy P. Hubbard et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Immunogenicity and Protection From a Single Dose of Internationally Available Killed Oral Cholera Vaccine: A Systematic Review and Metaanalysis
Anna Lena Lopez et al.
CLINICAL INFECTIOUS DISEASES (2018)
Sublingual Adjuvant Delivery by a Live Attenuated Vibrio cholerae-Based Antigen Presentation Platform
Julie Liao et al.
MSPHERE (2018)
Immunity Provided by an Outer Membrane Vesicle Cholera Vaccine Is Due to O-Antigen-Specific Antibodies Inhibiting Bacterial Motility
Zhu Wang et al.
INFECTION AND IMMUNITY (2017)
PaxVax CVD 103-HgR single-dose live oral cholera vaccine
Myron M. Levine et al.
EXPERT REVIEW OF VACCINES (2017)
Production of putative enhanced oral cholera vaccine strains that express toxin-coregulated pilus
Caitlyn A. Hauke et al.
PLOS ONE (2017)
Vibrio cholerae type 6 secretion system effector trafficking in target bacterial cells
Brian T. Ho et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Genomic history of the seventh pandemic of cholera in Africa
Francois-Xavier Weill et al.
SCIENCE (2017)
Integrated view of Vibrio cholerae in the Americas
Daryl Domman et al.
SCIENCE (2017)
Single-dose Live Oral Cholera Vaccine CVD 103-HgR Protects Against Human Experimental Infection With Vibrio cholerae O1 El Tor
Wilbur H. Chen et al.
CLINICAL INFECTIOUS DISEASES (2016)
Quorum sensing signal-response systems in Gram-negative bacteria
Kai Papenfort et al.
NATURE REVIEWS MICROBIOLOGY (2016)
Efficacy of a Single-Dose, Inactivated Oral Cholera Vaccine in Bangladesh
Firdausi Qadri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Construction and preclinical evaluation of mmCT, a novel mutant cholera toxin adjuvant that can be efficiently produced in genetically manipulated Vibrio cholerae
Michael Lebens et al.
VACCINE (2016)
The oral cholera vaccine Shanchol™ when stored at elevated temperatures maintains the safety and immunogenicity profile in Bangladeshi participants
Amit Saha et al.
VACCINE (2016)
Single-Cell Analysis of the Plasmablast Response to Vibrio cholerae Demonstrates Expansion of Cross-Reactive Memory B Cells
Robert C. Kauffman et al.
MBIO (2016)
Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trial
Firdausi Qadri et al.
LANCET (2015)
A globally distributed mobile genetic element inhibits natural transformation of Vibrio cholerae
Ankur B. Dalia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Whole-genome sequence comparisons reveal the evolution of Vibrio cholerae O1
Eun Jin Kim et al.
TRENDS IN MICROBIOLOGY (2015)
Peru-15 (Choleragarde®), a live attenuated oral cholera vaccine, is safe and immunogenic in human immunodeficiency virus (HIV)-seropositive adults in Thailand
W. Ratanasuwan et al.
VACCINE (2015)
Inactivated Influenza Vaccine That Provides Rapid, Innate-Immune-System-Mediated Protection and Subsequent Long-Term Adaptive Immunity
Brendon Y. Chua et al.
MBIO (2015)
A Cholera Conjugate Vaccine Containing O-specific Polysaccharide (OSP) of V. cholerae O1 Inaba and Recombinant Fragment of Tetanus Toxin Heavy Chain (OSP:rTTHc) Induces Serum, Memory and Lamina Proprial Responses against OSP and Is Protective in Mice
Md. Abu Sayeed et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
Flexibility of Oral Cholera Vaccine Dosing-A Randomized Controlled Trial Measuring Immune Responses Following Alternative Vaccination Schedules in a Cholera Hyper-Endemic Zone
Suman Kanungo et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
Updated Global Burden of Cholera in Endemic Countries
Mohammad Ali et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
A combined vaccine approach against Vibrio cholerae and ETEC based on outer membrane vesicles
Deborah R. Leitner et al.
Frontiers in Microbiology (2015)
Members of the human gut microbiota involved in recovery from Vibrio cholerae infection
Ansel Hsiao et al.
NATURE (2014)
Use of Vibrio cholerae Vaccine in an Outbreak in Guinea
Francisco J. Luquero et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Safety and Immunogenicity of a Live Oral Recombinant Cholera Vaccine VA1.4: A Randomized, Placebo Controlled Trial in Healthy Adults in a Cholera Endemic Area in Kolkata, India
Suman Kanungo et al.
PLOS ONE (2014)
Development of Stable Vibrio cholerae O1 Hikojima Type Vaccine Strains Co-Expressing the Inaba and Ogawa Lipopolysaccharide Antigens
Stefan L. Karlsson et al.
PLOS ONE (2014)
Proteomic analysis of Vibrio cholerae outer membrane vesicles
Emrah Altindis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Multiplex genome editing by natural transformation
Ankur B. Dalia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
ARTIST: High-Resolution Genome-Wide Assessment of Fitness Using Transposon-Insertion Sequencing
Justin R. Pritchard et al.
PLOS GENETICS (2014)
Evaluation in Mice of a Conjugate Vaccine for Cholera Made from Vibrio cholerae O1 (Ogawa) O-Specific Polysaccharide
Mohammad Murshid Alam et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Tn-Seq Analysis of Vibrio cholerae Intestinal Colonization Reveals a Role for T6SS-Mediated Antibacterial Activity in the Host
Yang Fu et al.
CELL HOST & MICROBE (2013)
Herd Protection by a Bivalent Killed Whole-Cell Oral Cholera Vaccine in the Slums of Kolkata, India
Mohammad Ali et al.
CLINICAL INFECTIOUS DISEASES (2013)
Lipopolysaccharide Modifications of a Cholera Vaccine Candidate Based on Outer Membrane Vesicles Reduce Endotoxicity and Reveal the Major Protective Antigen
Deborah R. Leitner et al.
INFECTION AND IMMUNITY (2013)
5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial
Sujit Bhattacharya et al.
LANCET INFECTIOUS DISEASES (2013)
Immunization with Cholera Toxin B Subunit Induces High-Level Protection in the Suckling Mouse Model of Cholera
Gregory A. Price et al.
PLOS ONE (2013)
Gene Fitness Landscapes of Vibrio cholerae at Important Stages of Its Life Cycle
Heather D. Kamp et al.
PLOS PATHOGENS (2013)
Transcutaneous Immunization with a Vibrio cholerae O1 Ogawa Synthetic Hexasaccharide Conjugate following Oral Whole-Cell Cholera Vaccination Boosts Vibriocidal Responses and Induces Protective Immunity in Mice
A. A. Tarique et al.
CLINICAL AND VACCINE IMMUNOLOGY (2012)
Immune responses to cholera in children
Daniel T. Leung et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2012)
Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study
Ahmed M. Khatib et al.
LANCET INFECTIOUS DISEASES (2012)
Support for a cholera vaccine stockpile
Agnes Binagwaho et al.
NATURE (2012)
Evaluation of TcpF-A2-CTB Chimera and Evidence of Additive Protective Efficacy of Immunizing with TcpF and CTB in the Suckling Mouse Model of Cholera
Gregory A. Price et al.
PLOS ONE (2012)
Protection and Attachment of Vibrio cholerae Mediated by the Toxin-Coregulated Pilus in the Infant Mouse Model
Shelly J. Krebs et al.
JOURNAL OF BACTERIOLOGY (2011)
Natural Cholera Infection-Derived Immunity in an Endemic Setting
Mohammad Ali et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Evidence for several waves of global transmission in the seventh cholera pandemic
Ankur Mutreja et al.
NATURE (2011)
Use of Oral Cholera Vaccines in an Outbreak in Vietnam: A Case Control Study
Dang Duc Anh et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
The Case for Reactive Mass Oral Cholera Vaccinations
Rita Reyburn et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
Review of oral cholera vaccines: efficacy in young children
Cristina Masuet-Aumatell et al.
Infection and Drug Resistance (2011)
Mucosal Immunization with Vibrio cholerae Outer Membrane Vesicles Provides Maternal Protection Mediated by Antilipopolysaccharide Antibodies That Inhibit Bacterial Motility
Anne L. Bishop et al.
INFECTION AND IMMUNITY (2010)
A National Cholera Vaccine Stockpile - A New Humanitarian and Diplomatic Resource
Matthew K. Waldor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Secretory IgA-mediated protection against V. cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccine
Daisuke Tokuhara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Engineered bacterial communication prevents Vibrio cholerae virulence in an infant mouse model
Faping Duan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Development of Peru-15 (CholeraGarde®), a live-attenuated oral cholera vaccine: 1991-2009
Mohiul Islam Chowdhury et al.
EXPERT REVIEW OF VACCINES (2009)
Host-Pathogen Interactions of Actinobacillus pleuropneumoniae with Porcine Lung and Tracheal Epithelial Cells
Eliane Auger et al.
INFECTION AND IMMUNITY (2009)
A Rice-Based Oral Cholera Vaccine Induces Macaque-Specific Systemic Neutralizing Antibodies but Does Not Influence Pre-Existing Intestinal Immunity
Tomonori Nochi et al.
JOURNAL OF IMMUNOLOGY (2009)
Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial
Dipika Sur et al.
LANCET (2009)
Transcutaneous immunization with a synthetic hexasaccharide-protein conjugate induces anti-Vibrio cholerae lipopolysaccharide responses in mice
Julianne E. Rollenhagen et al.
VACCINE (2009)
Randomized, double-blind, placebo-controlled trial to evaluate the safety and immunogenicity of live oral cholera vaccine 638 in Cuban adults
Rodrigo Valera et al.
VACCINE (2009)
Randomized placebo controlled human volunteer trial of a live oral cholera vaccine VA1.3 for safety and immune response
D. Mahalanabis et al.
VACCINE (2009)
Immunization with Vibrio cholerae outer membrane vesicles induces protective immunity in mice
Stefan Schild et al.
INFECTION AND IMMUNITY (2008)
Mucosal penetration primes Vibrio cholerae for host colonization by repressing quorum sensing
Zhi Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Exploiting cholera vaccines as a versatile antigen delivery platform
Anisia J. Silva et al.
BIOTECHNOLOGY LETTERS (2008)
Peru-15, a live attenuated oral cholera vaccine, is safe and immunogenic in Bangladeshi toddlers and infants
Firdausi Qadri et al.
VACCINE (2007)
Transcutaneous immunization with toxin-coregulated pilin A induces protective immunity against Vibrio cholerae O1 El Tor challenge in mice
Julianne E. Rollenhagen et al.
INFECTION AND IMMUNITY (2006)
Live attenuated oral cholera vaccines
Edward T. Ryan et al.
EXPERT REVIEW OF VACCINES (2006)
Randomized, controlled study of the safety and immunogenicity of Peru-15, a live attenuated oral vaccine candidate for cholera, in adult volunteers in Bangladesh
F Qadri et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
TcpF is a soluble colonization factor and protective antigen secreted by El Tor and classical O1 and O139 Vibrio cholerae serogroups
TJ Kirn et al.
INFECTION AND IMMUNITY (2005)
Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis
M Ali et al.
LANCET (2005)
The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers
L García et al.
INFECTION AND IMMUNITY (2005)
The major subunit of the toxin-coregulated pilus TcpA induces mucosal and systemic immunoglobulin A immune responses in patients with cholera caused by Vibrio cholerae O1 and O139
M Asaduzzaman et al.
INFECTION AND IMMUNITY (2004)
Incomplete correlation of serum vibriocidal antibody titer with protection from Vibrio cholerae infection in urban Bangladesh
D Saha et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Quorum sensing-dependent biofilms enhance colonization in Vibrid cholerae
J Zhu et al.
DEVELOPMENTAL CELL (2003)
Randomized, controlled human challenge study of the safety, immunogenicity, and protective efficacy of a single dose of Peru-15, a live attenuated oral cholera vaccine
MB Cohen et al.
INFECTION AND IMMUNITY (2002)
Quorum-sensing regulators control virulence gene expression in Vibrio cholerae
J Zhu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Preparation, immunogenicity, and protective efficacy, in a murine model, of a conjugate vaccine composed of the polysaccharide moiety of the lipopolysaccharide of Vibrio cholerae O139 bound to tetanus toxoid
A Boutonnier et al.
INFECTION AND IMMUNITY (2001)
Construction and characterization of a nonproliferative El Tor cholera vaccine candidate derived from strain 638
E Valle et al.
INFECTION AND IMMUNITY (2000)
Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area
E Richie et al.
VACCINE (2000)
Share Paper
